1-3 of 3
Elizabeth Hall-Meyers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells

Ellen Weisberg, Johannes Roesel, Guido Bold, Pascal Furet, Jingrui Jiang, Jan Cools, Renee D. Wright, Erik Nelson, Rosemary Barrett, Arghya Ray, Daisy Moreno, Elizabeth Hall-Meyers, Richard Stone, Ilene Galinsky, Edward Fox, Gary Gilliland, John F. Daley, Suzan Lazo-Kallanian, Andrew L. Kung, James D. Griffin
Journal: Blood
Blood (2008) 112 (13): 5161–5170.
https://doi.org/10.1182/blood-2008-02-138065
Published: 2008
Includes: Supplemental data
Journal Articles

Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL– and mutant FLT3-expressing cells

Ellen Weisberg, Lolita Banerji, Renee D. Wright, Rosemary Barrett, Arghya Ray, Daisy Moreno, Laurence Catley, Jingrui Jiang, Elizabeth Hall-Meyers, Maira Sauveur-Michel, Richard Stone, Ilene Galinsky, Edward Fox, Andrew L. Kung, James D. Griffin
Journal: Blood
Blood (2008) 111 (7): 3723–3734.
https://doi.org/10.1182/blood-2007-09-114454
Published: 2008
Includes: Supplemental data
Journal Articles

Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL + leukemias

Ellen Weisberg, Laurie Catley, Renee D. Wright, Daisy Moreno, Lolita Banerji, Arghya Ray, Paul W. Manley, Juergen Mestan, Doriano Fabbro, Jingrui Jiang, Elizabeth Hall-Meyers, Linda Callahan, Jamie L. DellaGatta, Andrew L. Kung, James D. Griffin
Journal: Blood
Blood (2006) 109 (5): 2112–2120.
https://doi.org/10.1182/blood-2006-06-026377
Published: 2006
Includes: Supplemental data